Brain natriuretic peptide: A potential marker for mortality in septic shock

International Journal of Infectious Diseases

Volumn 8, Issue 5, 2004, Pages 271-274

  Castillo, Jose R ^a   Zagler, Axel ^a   Carrillo Jimenez, Rodolfo ^a   Hennekens, Charles H ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Brain natriuretic peptide; Myocardial dysfunction; Sepsis; Septic shock

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE;

COST BENEFIT ANALYSIS; DISEASE MARKER; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART RATE; HEMODYNAMICS; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MORTALITY; NONHUMAN; OXYGEN SUPPLY; PROGNOSIS; PROTEIN BLOOD LEVEL; PUBLIC HEALTH; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL;

EID: 4344713312     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2003.12.007     Document Type: Article

References (24)

1. N. Valli, A. Gobinet, and L. Bordenave Review of ten years of the clinical use of brain natriuretic peptide in cardiology J Lab Clin Med. 134 1999 437 444
2. M.R. Cowie, A.D. Struthers, D.A. Wood, A.J.S. Coats, S.G. Thompson, and P.A. Poole-Wilson Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet. 350 1997 1349 1353
3. K. Yamamoto, J.C. Burnett, E.A. Bermudez, M. Jougasaki, K.R. Bailey, and M.M. Redfield Clinical criteria and biochemical markers for the detection of systolic dysfunction J Cardiac Fail. 6 2000 194 200
4. T. Suzuki, K. Yamaoki, O. Nakajima, T. Yamazaki, Y. Yamada, and H. Akioka Screening for cardiovascular dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels Jpn Heart J 41 2000 205 214
5. T.A. McDonagh, S.D. Robb, J.J. Morton, I. Ford, C.E. Morrison, and H. Tunstall-Pedoe Biochemical detection of left ventricular systolic dysfunction Lancet 351 1998 9 13
6. R. Hotchkiss, and I. Karl The pathophysiology and treatment of sepsis New Engl J Med. 348 2003 138 150
7. O. Court, A. Kumar, J. Parrillo, and A. Kumar Clinical review: Myocardial depression in sepsis and septic shock Crit Care. 6 2000 500 508
8. A. Kumar, and J. Osman Septic myocardial depression: No "no" to NO? Crit Care Med. 29 2001 202 203
9. M.M. Parker, A.F. Suffredini, C. Natanson, F.P. Ognibene, J.H. Shelhamer, and J.E. Parrillo Responses of left ventricular function in survivors and non-survivors of septic shock J Crit Care. 4 1989 19 25
10. M.M. Parker, J.H. Shelhamer, S.L. Bacharach, M.V. Green, C. Natanson, and T.M. Frederick Profound but reversible myocardial depression in patients with septic shock Ann Intern Med. 10 1984 483 490
11. F.P. Ognibene, M.M. Parker, C. Natanson, J.H. Shelhamer, and J.E. Parrillo Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock Chest 93 1988 903 910
12. A. Kimchi, A.G. Ellrodt, D.S. Berman, G.H. Murata, M.S. Riedinger, and H.J. Swan Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study J Am Coll Cardiol 4 1984 945 951
13. M.M. Parker, K.E. McCarthy, F.P. Ognibene, and J.E. Parrillo Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans Chest. 97 1990 126 131
14. S.M. Jafri, S. Lavine, B.E. Field, M.C. Thill-Baharozian, and R.W. Carlson Left ventricular diastolic function in sepsis Crit Care Med. 18 1991 709 714
15. B. Munt, J. Jue, K. Gin, J. Fenwick, and M. Tweeddale Diastolic filling in human severe sepsis: an echocardiographic study Crit Care Med. 26 1998 1829 1833
16. J. Poelaert, C. Declerck, D. Vogelaers, F. Colardyn, and C.A. Visser Left ventricular systolic and diastolic function in septic shock Intensive Care Med. 23 1997 553 560
17. A.J. Schneider, Teule GJJ, Groenveld ABJ, J. Nauta, Heidendal GAK, and L.G. Thijs Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: a combined hemodynamic and radionuclide study Am Heart J 116 1988 103 112
18. J.L. Vincent, C. Reuse, N. Frank, B. Contempre, and R.J. Kahn Right ventricular dysfunction in septic shock: assessment by measurement of right ventricular ejection fraction using the thermodilution technique Acta Anaesthesiol Scand. 33 1989 34 38
19. K.J. Hartemink, J. Groeneveld, M.C. de Groot, R.J. Strack van Schijndel, and G. van Kamp Thijs LG. α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock Crit Care Med. 29 2001 80 87
20. B. Mazul-Sunko, N. Zarkovic, N. Vrkic, R. Klinger, M. Peric, and M. Bekavac-Beslin Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients J Endocrinol Invest. 24 2001 RC22 RC24
21. N. Hama, H. Itoh, G. Shirakami, S. Suga, Y. Komatsu, and T. Yoshimasa Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients Biochem Biophys Res Commun. 198 1994 1177 1182
22. R. Witthaut, C. Busch, P. Fraunberger, A. Walli, D. Seidel, and G. Pilz Plasma natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction Intensive Care Med. 29 2003 1696 1702
23. R. Carrillo-Jimenez, G. Lamas, and C.H. Hennekens Plasma level of brain natriuretic peptide: a potential marker for HIV-related cardiomyopathy J Cardiovascular Pharmacol Ther. 7 2002 135 137
24. Carrillo-Jimenez R, Treadwell T, Goldfine H, Buenano A, Lamas G, Hennekens CH. Brain natriuretic peptide and HIV-related cardiomyopathy. AIDS Read 2002;12:501-3, 508.